155 followers
Loss of PDPK1 abrogates resistance to gemcitabine in label-retaining pancreatic cancer cells. https://t.co/7QIDv7TsDa
Loss of PDPK1 abrogates resistance to gemcitabine in label-retaining pancreatic cancer cells. https://t.co/7QIDv7TsDa
New publication from my time as an @NCI_SurgOnc fellow in the @NCI_CCR_SB and @NCI_TGIB . Many thanks to persistence of Udo Rudloff and his lab for the teamwork. @PanCAN https://t.co/kk13TDUzt9